Example: Heart Attack

Search clinical trials for: Folic Acid

Total 4775 results

NCT04455594

Not yet recruiting

Almonertinib Vs. Erlotinib/Chemotherapy for Neo-adjuVant Treatment of Stage IIIA-N2 EGFR-mutated NSCLC

Conditions: Non-Small Cell Lung Cancer Stage IIIA
NCT04456699

Not yet recruiting

Efficacy and Safety of Olaparib, Olaparib + Bevacizumab Compared to Bevacizumab + 5-Fluorouracil (FU)

Conditions: Metastatic Colorectal Cancer
NCT04453345

Recruiting

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Conditions: T-LGL Leukemia; Clpd-Nk
NCT04453423

Not yet recruiting

Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer.

Conditions: Non-squamous Non-small-cell Lung Cancer
NCT04453761

Active, not recruiting

Thiamine Influenced on Substrate Energy Effectiveness in Indonesian Children Undergoing Cardiopulmonary Bypass

Conditions: Thiamine Deficiency; Congenital Heart Disease; Cardiopulmonary Bypass
NCT04451395

Not yet recruiting

Investigating Pathways Between Maternal Nutritional Status, Breastmilk Composition, and Infant Linear Growth in Rural Pakistan

Conditions: Breast Milk Collection; Infant Development
NCT04452461

Not yet recruiting

Pancreatic Adenocarcinoma Neoadjuvant Combination Chemotherapy and Stereotactic Body Radiation Therapy Before Surgery

Conditions: Pancreatic Adenocarcinoma
NCT04447092

Not yet recruiting

Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer

Conditions: Pancreatic Cancer; Chemotherapy Effect
NCT04447352

Not yet recruiting

HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)

Conditions: Gastric Cancer; Gastroesophageal Junction Adenocarcinoma
NCT04442984

Recruiting

FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)

Conditions: Gastric Carcinoma Stage IV; Esophagogastric Junction Adenocarcinoma Stage IV
NCT04439890

Recruiting

A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer

Conditions: Advanced Non-squamous Cell Non-small Cell Lung Cancer
NCT04440267

Not yet recruiting

Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

Conditions: Acute Leukemia of Ambiguous Lineage
NCT04436419

Completed

Immunometabolic Effects of Non-drug Strategies in the Clinical Management of Obesity: Translational Study

Conditions: Obesity; Obesity, Abdominal; Obesity, Visceral; Female
NCT04430933

Not yet recruiting

A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC

Conditions: Advanced or Metastatic Solid Tumors; Non-Small Cell Lung Cancer
NCT04430985

Not yet recruiting

FOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal Cancer

Conditions: Metastatic Colorectal Cancer
NCT04430517

Not yet recruiting

Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia

Conditions: Mild Cognitive Impairment; Alzheimer Disease
NCT04430738

Not yet recruiting

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy for HER2+ Gastrointestinal Cancers

Conditions: Colorectal Carcinoma; Gastric Adenocarcinoma; Esophageal and GEJ Adenocarcinoma; Cholangiocarcinoma; Gallbladder Carcinoma
NCT04425239

Recruiting

Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer

Conditions: Colorectal Cancer Stage IV
NCT04426591

Not yet recruiting

Red Blood Cell Survival in Sickle Cell Disease

Conditions: Sickle Cell Disease
NCT04427956

Recruiting

Corneal Crosslinking Treatment Study

Conditions: Progressive Keratoconus
NCT04422392

Not yet recruiting

Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer

Conditions: Non Small Cell Lung Cancer
NCT04423731

Recruiting

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer

Conditions: Locally Advanced Pancreatic Adenocarcinoma; Chemotherapy Effect; Borderline Resectable Pancreatic Adenocarcinoma; Pancreatectomy
NCT04424225

Not yet recruiting

Visual Surround Suppression and Perceptual Expectation Under Psilocybin

Conditions: Perception Disturbance
NCT04418895

Not yet recruiting

Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

Conditions: Rectal Adenocarcinoma
NCT04414527

Recruiting

Effects of Video-based Health Education on Maternal and Child Health in Ethiopia

Conditions: Anemia; Antenatal Care; Birth Outcomes; Worm Infection; Bacterial Vaginoses; Exclusive Breastfeeding
NCT04410796

Recruiting

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

Conditions: Metastatic Non-small Cell Lung Cancer
NCT04407390

Recruiting

Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly

Conditions: COVID
NCT04407572

Completed

Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women

Conditions: COVID; Zinc Deficiency; Vitamin D Deficiency
NCT04407754

Not yet recruiting

Myo-Inositol for Infertility in PCOS

Conditions: Polycystic Ovary Syndrome
NCT04405674

Not yet recruiting

Tislelizumab Combined With Chemotherapy in Patients With TKI-Resistant EGFR-Mutated Non-squamous NSCLC

Conditions: Non Small Cell Lung Cancer
NCT04404751

Recruiting

Quadruple Fortified Salt Clinical Trial

Conditions: Anemia
NCT04401865

Recruiting

Safety and Effectiveness of the PXL-Platinum 330 System

Conditions: Corneal Ectasia; Keratoconus; Pellucid Marginal Corneal Degeneration
NCT04398238

Not yet recruiting

Transfusion Rates in Total Hip Replacement Before/After the Implementation of a Patient Blood Management Program.

Conditions: Anemia (Diagnosis); Iron-deficiency; Transfusion; Arthroplasty
NCT04395768

Not yet recruiting

International ALLIANCE Study of Therapies to Prevent Progression of COVID-19

Conditions: COVID19
NCT04396223

Recruiting

Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment

Conditions: Gestational Trophoblastic Neoplasias (GTN)
NCT04396457

Not yet recruiting

Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901

Conditions: Non-squamous Non-small-cell Lung Cancer; Cancer, Lung
NCT04393584

Recruiting

FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma

Conditions: Stomach Neoplasms; Gastrointestinal Neoplasms; Docetaxel; Oxaliplatin; Fluoruracil; Irinotecan Hydrochloride
NCT04394611

Not yet recruiting

Metals and in Fetal Growth Restriction

Conditions: Fetal Growth Restriction
NCT04391452

Not yet recruiting

Dietary Supplement With Magnesium, Vitamins, Rhodiola and L-theanine Stressed Subjects: Randomized Study Versus Placebo (MAGRITTE)

Conditions: Stress, Psychological
NCT04392479

Not yet recruiting

TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study.

Conditions: Cancer Colorectal; Metastasis
NCT04390399

Recruiting

Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for First and Second Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Conditions: Pancreatic Cancer
NCT04386499

Completed

Biological Effects of Treatment With Resveratrol in ART Patients

Conditions: Infertility, Female
NCT04387201

Recruiting

GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response

Conditions: Glucose Intolerance; Overweight and Obesity; Drug Effect; Adiposity
NCT04383743

Not yet recruiting

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Conditions: Stage II Bladder Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8
NCT04384692

Not yet recruiting

Ruxolitinib for the Treatment of Graft Versus Host Disease Following Stem Cell Transplant in Patients With Primary and Secondary Myelofibrosis

Conditions: Primary Myelofibrosis; Secondary Myelofibrosis
NCT04380636

Recruiting

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Conditions: Lung Neoplasms; Carcinoma, Non-Small-Cell Lung
NCT04379219

Recruiting

Surgery Alone Versus Methotrexate Before Surgery in Cesarean Scar Pregnancy

Conditions: Cesarean Scar Pregnancy
NCT04379635

Recruiting

Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)

Conditions: Non Small Cell Lung Cancer
NCT04375605

Recruiting

Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ

Conditions: Gastroesophageal Junction Adenocarcinoma
NCT04372316

Recruiting

A Randomized Controlled Trial of Mecobalamin Injection and Tablet Treatment Efficacy on Mild to Moderate Diabetic Peripheral Neuropathy

Conditions: Diabetic Neuropathies